Rekindling old controversy on elusive lair of latent tuberculosis
- 30 December 2000
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 356 (9248) , 2113-2114
- https://doi.org/10.1016/s0140-6736(00)03485-1
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosisNature, 2000
- A Proposed National Strategy for Tuberculosis Vaccine DevelopmentClinical Infectious Diseases, 2000
- Global Burden of TuberculosisJAMA, 1999
- New Tuberculosis Drug DevelopmentAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Nitrate reduction as a marker for hypoxic shiftdown of Mycobacterium tuberculosisTubercle and Lung Disease, 1998
- Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 1994
- Pathogenesis of tuberculosis: pathway to apical localizationTubercle and Lung Disease, 1994
- Much's granules revisitedTubercle, 1987
- THE TREATED PULMONARY LESION AND ITS TUBERCLE BACILLUS.*The Lancet Healthy Longevity, 1956
- Types of tubercle bacilli in human tuberculosisThe Journal of Pathology and Bacteriology, 1929